Figure 2From: The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in SwedenCost- effectiveness acceptability curves for men and women. Each curve indicates, for a specific willingness-to-pay for an additional QLAY (horisontal axis), the likelihood (vertical axis) that GH treatment is cost-effective, compared to no treatment.Back to article page